I hate the title of being called the richest woman in India, but it's the recognition that this was the value that I had created as a woman entrepreneur and that makes me very, very proud.

An entrepreneur's life is always a continuous journey.

I do serve on various boards and I'm very honest and frank, obviously, I am a very forthright person and I do, sort of, share my candid views on anything.

One of my objectives when I started Biocon was to make sure that I create a company for women scientists to pursue a vocation.

Unfortunately our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon as a bellwether stock. A stock that is differentiated, a stock that is focused on R&D, and a very-very strong balance sheet with huge value drivers at the end of it.

I hate the title of being called the richest woman in India, but it's the recognition that this was the value that I had created as a woman entrepreneur and that makes me very, very proud.

My legacy is going to be in affordable health care. I am willing to invest in developing that model and the policies around it.